跳转至内容
Merck

G0500

Sigma-Aldrich

D-(+)-半乳糖胺 盐酸盐

≥99% (HPLC)

别名:

2-氨基-2-脱氧-D-半乳糖 盐酸盐, D-软骨糖胺 盐酸盐

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C6H13NO5 · HCl
CAS号:
分子量:
215.63
Beilstein:
3697825
EC號碼:
MDL號碼:
分類程式碼代碼:
12352201
PubChem物質ID:
NACRES:
NA.25

生物源

shark (cartilage)

化驗

≥99% (HPLC)

形狀

powder

技術

HPLC: suitable

雜質

≤0.5% Glucosamine (HPAE)

顏色

white to off-white

mp

172-180  °C

溶解度

H2O: 50 mg/mL, clear to slightly hazy, colorless to very faintly yellow

儲存溫度

room temp

SMILES 字串

Cl.N[C@@H](C=O)[C@@H](O)[C@@H](O)[C@H](O)CO

InChI

1S/C6H13NO5.ClH/c7-3(1-8)5(11)6(12)4(10)2-9;/h1,3-6,9-12H,2,7H2;1H/t3-,4+,5+,6-;/m0./s1

InChI 密鑰

CBOJBBMQJBVCMW-NQZVPSPJSA-N

正在寻找类似产品? 访问 产品对比指南

一般說明

D-半乳糖胺(d-GalN)是一种特异性肝毒剂,尤其可在肝细胞内代谢。它是一种源自半乳糖的6碳氨基糖。

應用

D-(+)-半乳糖盐酸盐已用于:
  • 甘露聚糖结合凝集素(MBL)与改性云母表面的表面结合
  • 腹腔注射前的无菌磷酸盐缓冲液(PBS)中
  • 小鼠中产生原发性骨髓来源的巨噬细胞(BMDM)

D-(+)-半乳糖胺(D-软骨胺)联合脂多糖(LPS)已用于诱导急性肝衰竭模型(LPS/D-GALN诱导肝损伤、肝炎)的治疗研究,以寻找新药。

生化/生理作用

半乳糖胺(Gal)通过细胞坏死和凋亡诱导肝细胞死亡。它通过产生尿苷二磷酸己糖胺来阻止肝RNA的产生。D-半乳糖胺可降低细胞内尿嘧啶核苷酸库,进而阻止RNA和蛋白质的产生。

其他說明

为了全面了解我们针对客户研究提供的各种单糖产品,建议您访问我们的碳水化合物分类页面。

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable

個人防護裝備

Eyeshields, Gloves, type N95 (US)


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

其他客户在看

Yating Li et al.
Applied microbiology and biotechnology, 103(1), 375-393 (2018-10-23)
Acute liver failure is a drastic, unpredictable clinical syndrome with high mortality. Various preventive and adjuvant therapies based on modulating the gut flora have been proposed for hepatic injury. We aimed to explore the preventive and therapeutic effects of Bifidobacterium
Xing Lin et al.
Biological & pharmaceutical bulletin, 37(4), 625-632 (2014-05-13)
This study examined the effect of genistein from Hydrocotyle sibthorpioides on lipopolysaccharide (LPS)/D-galactosamine (D-GalN)-induced acute hepatic failure. Compared to the model control, genistein treatment significantly protected against LPS/D-GalN-induced liver injury, as evidenced by the decrease in serum alanine and aspartate
Kaicen Wang et al.
mSphere, 5(1) (2020-01-31)
Acute liver failure is a severe liver disorder that poses considerable global challenges. Previous studies on Bifidobacterium longum R0175 have mainly focused on its psychotropic functions. The current research focused on the protective efficacy of B. longum R0175 against acute
Aoxiang Zhuge et al.
Applied microbiology and biotechnology, 104(17), 7437-7455 (2020-07-16)
Acute liver failure is a clinical emergency associated with high mortality. Accumulating evidence indicates that gut microbiota participates in the progression of liver injury, and preventive therapies based on altering gut microbiota are of great interest. Previous studies demonstrated that
Shan-Shan Li et al.
Molecular immunology, 101, 10-18 (2018-06-01)
Acute liver failure is a devastating clinical syndrome with extremely terrible inflammation reaction, which is still lack of effective treatment in clinic. Suppressor of Cytokine Signaling 1 protein is inducible intracellular negative regulator of Janus kinases (JAK)/signal transducers and activators

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门